← Back to news
Y

Yahoo Finance

“We Don’t See the Defense Demand Waning at All,” Says Honeywell International (HON)’s Jim Currier

Y

New Mexico jury approves $375M in civil damages against Meta

Y

Teradyne (TER) to Facilitate Production of High-Volume Silicon Photonics and Co-Packaged Optics with Photon 100 Launch

Y

Analysts Bullish on Costco Wholesale (COST) Despite Increasing Concerns Regarding Membership Growth Trends and Valuation

Y

Analysts Mixed on Norfolk Southern (NSC) Amid Pricing and Competition Concerns

Y

Nextpower (NXT) to Deliver Another Robust Quarter Despite Solar Industry Headwinds, According to Jefferies

Y

Punitive Damages Award Worth $950 Million Overturned Against Johnson & Johnson (JNJ), $16M Talc Verdict Stands

Y

When will I get my tax refund? How to check your IRS status.

Y

Corning (GLW) to Showcase New AI-Driven Optical Communication Breakthroughs At the Optical Fiber Communication Conference 2026

Y

Analysts Remain Confident in Reviva Pharmaceuticals Holdings (RVPH) Amid 1-for-20 Reverse Stock Split

Y

Dollar Supported by Ongoing US-Iran War

Y

Strong Analyst Sentiment on TScan Therapeutics (TCRX) Amid Ongoing Momentum in Cell Therapy Space

Y

Analysts Remain Optimistic in Sagimet Biosciences (SGMT)’s Outlook Following Q4 and Full-Year 2025 Results

Y

H.C. Wainwright Bullish on Altimmune (ALT) Amid Growing Focus on Treatments for Metabolic and Liver Diseases

Y

Analysts Sentiment on Biomea Fusion (BMEA) Remains Strong Amid Strong Diabetes Trial Results

Y

Wedbush Bullish on Black Diamond Therapeutics (BDTX) Following Progress in Silevertinib Program

Y

OpenAI Warns Investors Of 'Microsoft Dependency' Hazard

Y

Strong Analyst Sentiment on Alight (ALIT) Amid Confident Management Commentary

Y

This eVTOL Maker Lost Less Money Than Expected. What It Means for the Stock.

Y

Moderna Stock is Soaring. Is It Too Late to Buy?

Y

Growing Optimism About ProQR Therapeutics (PRQR)’s RNA Editing Platform and Future Clinical Catalysts

Y

CervoMed (CRVO)’s Q4 Results Feature Advancements in Its Neflamapimod Program for Dementia Lewy Bodies (DLB)

Y

Why Micron Stock Is Falling Today

Y

Oil Settles Lower As U.S. Makes Proposal to End Conflict

Y

5 Ripple Effects From the Strait of Hormuz Blockade Affecting Energy Stocks

Y

What Investors Should Know About One HeartFlow Insider's $2 Million Stock Sale

Y

Valeo breaks ground on $225m manufacturing plant in US

Y

As the Oil Shock Sends Energy Stocks Soaring, Buy These 3 Now

Y

Crude Oil Prices Slide on Hopes Diplomacy Will End Iran War

Y

‘Don’t leave’: the remote work guru who nailed the labor market during the Great Resignation offers job advice for 2026

Y

Nat-Gas Prices Recover on Concern Over Tighter Global Supplies

Y

Binance Requests Market Maker Transparency in Updated Trading Policy

Y

Hedge fund commits to Dubai even as Iranian attacks continue

Y

Why QQQM Is Riskier Than Its Low-Cost, Set-It-and-Forget-It Reputation Suggests

Y

Navitas (NVTS), ON Semiconductor (ON) And 3 More Stocks You Need To Be Watching

Y

With Lumentum (LITE) And Coherent (COHR) Surging, Onto Innovation (ONTO) Could Be Next

Y

Nu Holdings Ltd. (NU) Gets Upgraded to Buy From Neutral by UBS – Here’s Why

Y

Zillow expands pool of brokerage partners for pre-market offering

Y

Mortgage rates spike as Iran conflict continues

Y

Equinor ASA (EQNR) Bolsters Helicopter Capacity in Bergen

Y

JPMorgan Lifts PT on Vodafone Group (VOD) to 85 GBp From 71 GBp – Here’s Why

Y

Interactive Brokers Makes It Easier To Move Crypto Onto Its Platform

Y

FDA Grants Breakthrough Therapy Designation to Venglustat in the US, Sanofi (SNY) Reports

Y

Petrobras (PBR) Announces New Gas Discovery in Colombia

Y

Deutsche Bank Lifts PT on Prudential plc (PUK) to 1,440 GBp From 1,355 GBp – Here’s Why

Y

DA Davidson Cuts PT on Huntington Bancshares (HBAN) to $20 From $21 – Here’s Why

Y

TD Cowen Lifts PT on Devon Energy (DVN) to $50 From $46 – Here’s Why

Y

JetBlue Rockets 18% on Partnership News: Is JBLU Leaving Delta and American Airlines Behind?

Y

Prediction: Micron Will Be One of the Best-Performing Stocks of 2026

Y

Bernstein Initiates Coverage of Novo Nordisk (NVO) With an Underperform Rating

Y